XSMO trades at 17.44x forward earnings and offers a 21% one-year estimated earnings per share growth rate. Read why XSMO ETF ...

M/M vs. +0.3% consensus and +0.1% prior, according to data released by the Bureau of Labor Statistics on Tuesday.

Objective Non-alcoholic fatty liver disease (NAFLD) is the leading cause of end-stage liver diseases worldwide. Understanding NAFLD prevalence and trends over time at the global, regional and national ...